Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma: results of the HD2002 prospective multicentre randomized phase III trial
In the multicentre prospective randomized HD2002 trial, rituximab maintenance therapy (375 mg/m2 every 3 months for 2 years) versus observation was evaluated for CD20+ B-cell lymphoma. Out of 321 patients [161 randomized to the treatment group (TG), 160 to the observation group (OG)], 295 data sets...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
9 October 2015
|
| In: |
British journal of haematology
Year: 2015, Volume: 171, Issue: 5, Pages: 710-719 |
| ISSN: | 1365-2141 |
| DOI: | 10.1111/bjh.13652 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1111/bjh.13652 Verlag, Volltext: http://onlinelibrary.wiley.com.ezproxy.medma.uni-heidelberg.de/doi/10.1111/bjh.13652/abstract 
|
| Author Notes: | Mathias Witzens-Harig, Axel Benner, Fabienne McClanahan, Jennifer Klemmer, Julia Brandt, Elke Brants, Michael Rieger, Julia Meissner, Manfred Hensel, Kai Neben, Peter Dreger, Eva Lengfelder, Ingo Schmidt-Wolf, Alwin Krämer and Anthony D. Ho |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1566315913 | ||
| 003 | DE-627 | ||
| 005 | 20240316100310.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 171212s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjh.13652 |2 doi | |
| 035 | |a (DE-627)1566315913 | ||
| 035 | |a (DE-576)496315919 | ||
| 035 | |a (DE-599)BSZ496315919 | ||
| 035 | |a (OCoLC)1340983452 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Witzens-Harig, Mathias |e VerfasserIn |0 (DE-588)1050736516 |0 (DE-627)784812322 |0 (DE-576)404988970 |4 aut | |
| 245 | 1 | 0 | |a Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma |b results of the HD2002 prospective multicentre randomized phase III trial |c Mathias Witzens-Harig, Axel Benner, Fabienne McClanahan, Jennifer Klemmer, Julia Brandt, Elke Brants, Michael Rieger, Julia Meissner, Manfred Hensel, Kai Neben, Peter Dreger, Eva Lengfelder, Ingo Schmidt-Wolf, Alwin Krämer and Anthony D. Ho |
| 264 | 1 | |c 9 October 2015 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.12.2017 | ||
| 520 | |a In the multicentre prospective randomized HD2002 trial, rituximab maintenance therapy (375 mg/m2 every 3 months for 2 years) versus observation was evaluated for CD20+ B-cell lymphoma. Out of 321 patients [161 randomized to the treatment group (TG), 160 to the observation group (OG)], 295 data sets were evaluable for statistical analysis. Estimated 5-year relapse-free survival (RFS) was 81% in the TG and 70% in the OG (logrank test, P = 0·047). In the diffuse large B-cell lymphoma (DLBCL) subgroup (n = 152), 5-year RFS was excellent, at 87% in the TG and 84% in the OG (logrank test, P = 0·35). Of note, only in male patients of the DLBCL subgroup was RFS significantly superior in the TG in comparison to the OG (5-year RFS: 88% vs. 74%; logrank test, P = 0·05). Cox regression analysis showed a significant interaction between treatment and gender regarding overall survival (OS) (P = 0·006) and RFS (P = 0·02), with a lower hazard in females than males in the OG [OS: hazard ratio (HR) (female:male) = 0·11; 95% confidence interval (CI) = 0·00-1·03; RFS: HR (female:male) = 0·27; 95% CI = 0·05-0·97], and no significant differences between males and females in the TG. We conclude that Rituximab maintenance therapy improves survival in male patients with DLBCL. | ||
| 650 | 4 | |a diffuse large B-cell lymphoma | |
| 650 | 4 | |a gender differences | |
| 650 | 4 | |a multicentre prospective randomized trial | |
| 650 | 4 | |a rituximab maintenance therapy | |
| 700 | 1 | |a Klemmer, Jennifer |e VerfasserIn |0 (DE-588)1148699570 |0 (DE-627)1008959626 |0 (DE-576)496404741 |4 aut | |
| 700 | 1 | |a Brandt, Julia |e VerfasserIn |0 (DE-588)1148788085 |0 (DE-627)1009188453 |0 (DE-576)496434985 |4 aut | |
| 700 | 1 | |a Brants, Elke |e VerfasserIn |0 (DE-588)1148787860 |0 (DE-627)1009188194 |0 (DE-576)496434705 |4 aut | |
| 700 | 1 | |a Meißner, Julia |e VerfasserIn |0 (DE-588)1236765966 |0 (DE-627)176254850X |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Lengfelder, Eva |d 1951- |e VerfasserIn |0 (DE-588)1031229779 |0 (DE-627)736022775 |0 (DE-576)378669230 |4 aut | |
| 700 | 1 | |a Krämer, Alwin |e VerfasserIn |0 (DE-588)1067780025 |0 (DE-627)819183431 |0 (DE-576)426900820 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of haematology |d Oxford [u.a.] : Wiley-Blackwell, 1955 |g 171(2015), 5, Seite 710-719 |h Online-Ressource |w (DE-627)269758941 |w (DE-600)1475751-5 |w (DE-576)09113997X |x 1365-2141 |7 nnas |a Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma results of the HD2002 prospective multicentre randomized phase III trial |
| 773 | 1 | 8 | |g volume:171 |g year:2015 |g number:5 |g pages:710-719 |g extent:10 |a Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma results of the HD2002 prospective multicentre randomized phase III trial |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjh.13652 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://onlinelibrary.wiley.com.ezproxy.medma.uni-heidelberg.de/doi/10.1111/bjh.13652/abstract |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20171212 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 15 |y j | ||
| 998 | |g 1067780025 |a Krämer, Alwin |m 1067780025:Krämer, Alwin |d 60000 |d 61400 |e 60000PK1067780025 |e 61400PK1067780025 |k 0/60000/ |k 1/60000/61400/ |p 14 | ||
| 998 | |g 1031229779 |a Lengfelder, Eva |m 1031229779:Lengfelder, Eva |d 60000 |d 61200 |e 60000PL1031229779 |e 61200PL1031229779 |k 0/60000/ |k 1/60000/61200/ |p 12 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 11 | ||
| 998 | |g 1236765966 |a Meißner, Julia |m 1236765966:Meißner, Julia |d 910000 |d 910100 |e 910000PM1236765966 |e 910100PM1236765966 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 1148787860 |a Brants, Elke |m 1148787860:Brants, Elke |d 910000 |d 910100 |e 910000PB1148787860 |e 910100PB1148787860 |k 0/910000/ |k 1/910000/910100/ |p 6 | ||
| 998 | |g 1148788085 |a Brandt, Julia |m 1148788085:Brandt, Julia |d 910000 |d 910100 |e 910000PB1148788085 |e 910100PB1148788085 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1148699570 |a Klemmer, Jennifer |m 1148699570:Klemmer, Jennifer |d 910000 |d 910100 |e 910000PK1148699570 |e 910100PK1148699570 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1050736516 |a Witzens-Harig, Mathias |m 1050736516:Witzens-Harig, Mathias |d 910000 |d 910100 |e 910000PW1050736516 |e 910100PW1050736516 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1566315913 |e 2989785329 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"9 October 2015"}],"recId":"1566315913","type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"language":["eng"],"part":{"text":"171(2015), 5, Seite 710-719","year":"2015","volume":"171","issue":"5","pages":"710-719","extent":"10"},"title":[{"title":"British journal of haematology","subtitle":"BJHaem : an official journal of the British Society for Haematology","title_sort":"British journal of haematology"}],"pubHistory":["1.1955 -"],"name":{"displayForm":["ed. R. B. Thompson [u.a.]"]},"corporate":[{"display":"British Society for Haematology","role":"isb"},{"display":"European Hematology Association","role":"isb"}],"note":["Gesehen am 08.05.08"],"disp":"Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma results of the HD2002 prospective multicentre randomized phase III trialBritish journal of haematology","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1475751-5"],"issn":["1365-2141"],"doi":["10.1111/(ISSN)1365-2141"],"eki":["269758941"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"the official journal of the British Society of Haematology"},{"title":"BJH ; the official journal of the British Society for Haematology"}],"recId":"269758941","origin":[{"publisher":"Wiley-Blackwell ; Blackwell Science ; Blackwell","dateIssuedDisp":"1955-","dateIssuedKey":"1955","publisherPlace":"Oxford [u.a.] ; Oxford ; Oxford [u.a.]"}]}],"note":["Gesehen am 12.12.2017"],"physDesc":[{"extent":"10 S."}],"id":{"eki":["1566315913"],"doi":["10.1111/bjh.13652"]},"name":{"displayForm":["Mathias Witzens-Harig, Axel Benner, Fabienne McClanahan, Jennifer Klemmer, Julia Brandt, Elke Brants, Michael Rieger, Julia Meissner, Manfred Hensel, Kai Neben, Peter Dreger, Eva Lengfelder, Ingo Schmidt-Wolf, Alwin Krämer and Anthony D. Ho"]},"person":[{"display":"Witzens-Harig, Mathias","given":"Mathias","role":"aut","family":"Witzens-Harig"},{"display":"Klemmer, Jennifer","given":"Jennifer","role":"aut","family":"Klemmer"},{"display":"Brandt, Julia","role":"aut","given":"Julia","family":"Brandt"},{"role":"aut","given":"Elke","display":"Brants, Elke","family":"Brants"},{"family":"Meißner","display":"Meißner, Julia","given":"Julia","role":"aut"},{"family":"Dreger","given":"Peter","role":"aut","display":"Dreger, Peter"},{"family":"Lengfelder","given":"Eva","role":"aut","display":"Lengfelder, Eva"},{"display":"Krämer, Alwin","role":"aut","given":"Alwin","family":"Krämer"},{"display":"Ho, Anthony Dick","given":"Anthony Dick","role":"aut","family":"Ho"}],"language":["eng"],"title":[{"title":"Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma","subtitle":"results of the HD2002 prospective multicentre randomized phase III trial","title_sort":"Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma"}]} | ||
| SRT | |a WITZENSHARRITUXIMABM9201 | ||